Work

Sarcopenia and Clinical Phenotypes in Psoriatic Arthritis: Current Evidence and Future Directions

Year: 2026
Type: article
Abstract: Objectives. To review the evidence on sarcopenia in psoriatic arthritis (PsA) and to examine whether its occurrence differs among the clinical phenotypes of the disease. Methods. Narrative review based on searches of PubMed/MEDLINE, Scopus, Web of Science and Google Scholar up to March 2026, with an updated PubMed search in August 2026. Original studies, systematic reviews, guidelines and consensus documents on muscle mass, muscle strength, physical performance, body composition and sarcopenia in PsA were synthesized qualitatively; mechanistic evidence from other conditions was used only to generate hypotheses. Results. Seven studies reported muscle outcomes in PsA cohorts, one of them combined with axial spondyloarthritis. Sarcopenia frequency ranged from 5.1% to 43.1%, a spread that largely reflects differences in definitions and populations. Compared with controls, patients with PsA had lower muscle mass and higher fat mass, and sarcopenic obesity emerged as a relevant body-composition pattern. No study analyzed sarcopenia by clinical phenotype, and phenotype classification is complicated by overlapping manifestations that may change over time. Systemic inflammation, pain-related disuse, structural damage and obesity provide plausible but untested explanations for possible phenotype-specific differences. Conclusions. Whether sarcopenia differs among PsA phenotypes is unknown. In practice, muscle assessment should be guided by clinical findings rather than by phenotype. Prospective studies using standardized sarcopenia and sarcopenic-obesity criteria, explicit rules for classifying overlapping phenotypes and adjustment for obesity are required before phenotype-oriented screening or rehabilitation can be recommended.
Source: Arta Medica
Language: English
Subfield: Rheumatology
Field: Medicine
Open Access status: diamond
OpenAlex ID: W7226001825
FWCI:
Cites:
Cited by:
Related to: 10